0001209191-19-029668.txt : 20190514
0001209191-19-029668.hdr.sgml : 20190514
20190514163527
ACCESSION NUMBER: 0001209191-19-029668
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190513
FILED AS OF DATE: 20190514
DATE AS OF CHANGE: 20190514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Douville Philippe
CENTRAL INDEX KEY: 0001771205
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 19823274
MAIL ADDRESS:
STREET 1: C/O MILESTONE PHARMACEUTICALS, INC.
STREET 2: 1111 DR. FREDERIK-PHILIPS BLVD., STE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
BUSINESS ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-13
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001771205
Douville Philippe
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTR?AL
A8
H4M 2X6
QUEBEC, CANADA
0
1
0
0
Chief Scientific Officer
Common Shares
2019-05-13
4
C
0
4124
A
43392
D
Class A-1 Preferred
2019-05-13
4
C
0
4124
0.00
D
Common Shares
4124
0
D
Each share of Class A-1 Preferred was convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, had no expiration date and converted into Common Shares upon the closing of the Issuer's initial public offering.
/s/ Eric Popp, Attorney-in-Fact
2019-05-14